Bakkt Holdings, Inc. Form 8-K Summary
Business context and reporting period
Bakkt Holdings, Inc. filed a Current Report on Form 8-K dated March 13, 2024. The filing reports a continued-listing deficiency involving the company’s Class A common stock on the New York Stock Exchange (NYSE). It is not a periodic financial report.
Key financial and listing metrics
- The company’s average closing stock price was below $1.00 per share for 30 consecutive trading days.
- NYSE Regulation notified Bakkt that it was not in compliance with Section 802.01C of the NYSE Listed Company Manual.
- The filing does not provide current revenue, profit, cash flow, margin, debt, cash, or liquidity figures.
Material changes and required remediation
Bakkt has six months from the NYSE notification to regain compliance, while its Class A common stock is expected to remain listed during that period. The company stated that it will consider available alternatives, including a reverse stock split, subject to stockholder approval.
If a stockholder-approved action is used, the deficiency may be cured if the stock price promptly exceeds $1.00 and remains above that level for at least 30 trading days, subject to applicable NYSE requirements.
Outlook, risks, and unusual items
Management’s statements regarding curing the deficiency, returning to NYSE compliance, and considering a reverse stock split are forward-looking. The filing cautions that Bakkt may be unable to maintain its NYSE listing.
Other disclosed risks include the company’s ability to continue as a going concern, meet liquidity needs and future capital requirements, grow profitably, manage regulatory and crypto-market risks, access banking services, execute its growth strategy, maintain internal controls, protect data, and avoid litigation or impairment charges.
Important facts for investors to verify
- The deadline for Bakkt to regain compliance and any subsequent NYSE status updates.
- Whether Bakkt submits a reverse stock split or another remediation plan for stockholder approval.
- Whether the share price exceeds $1.00 and remains above that level for the required 30-trading-day period.
- Any effect on the company’s NYSE listing, Class A common stock, and warrants.
- Current liquidity, going-concern disclosures, and capital requirements in Bakkt’s latest periodic filing, which are not provided in this 8-K.